Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,215,022
+$283,295 QoQ
Shares Held
1,013
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2,953
of 4,605 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Leisure Capital Management holds $8,739,538 across 6 Drug Manufacturers - General names. LLY ranks #4 (13.9% of the industry book) .
All Filings in LLY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,215,022 | 1,013 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $931,727 | 1,013 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,087,576 | 1,012 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $814,121 | 1,067 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $824,742 | 1,058 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $873,812 | 1,058 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $829,128 | 1,074 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $948,841 | 1,071 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $968,756 | 1,070 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $833,195 | 1,071 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $533,371 | 915 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $491,473 | 915 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $435,213 | 928 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $730,797 | 2,128 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $778,507 | 2,128 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $688,088 | 2,128 | Shares | Sole | 2022-11-01 | |
| No filing history on record for this holder in this stock. | ||||||